Literature DB >> 23331357

Estimating fatality rates in occupational light vehicle users using vehicle registration and crash data.

Rwth Stuckey1, Anthony D LaMontagne, Deborah C Glass, Malcolm R Sim.   

Abstract

OBJECTIVE: To estimate occupational light vehicle (OLV) fatality numbers using vehicle registration and crash data and compare these with previous estimates based on workers' compensation data.
METHOD: New South Wales (NSW) Roads and Traffic Authority (RTA) vehicle registration and crash data were obtained for 2004. NSW is the only Australian jurisdiction with mandatory work-use registration, which was used as a proxy for work-relatedness. OLV fatality rates based on registration data as the denominator were calculated and comparisons made with published 2003/04 fatalities based on workers' compensation data.
RESULTS: Thirty-four NSW RTA OLV-user fatalities were identified, a rate of 4.5 deaths per 100,000 organisationally registered OLV, whereas the Australian Safety and Compensation Council (ASCC), reported 28 OLV deaths Australia-wide.
CONCLUSIONS: More OLV user fatalities were identified from vehicle registration-based data than those based on workers' compensation estimates and the data are likely to provide an improved estimate of fatalities specific to OLV use. IMPLICATIONS: OLV-use is an important cause of traumatic fatalities that would be better identified through the use of vehicle-registration data, which provides a stronger evidence base from which to develop policy responses.
© 2010 The Authors. Journal Compilation © 2010 Public Health Association of Australia.

Entities:  

Mesh:

Year:  2010        PMID: 23331357     DOI: 10.1111/j.1753-6405.2010.00498.x

Source DB:  PubMed          Journal:  Aust N Z J Public Health        ISSN: 1326-0200            Impact factor:   2.939


  1 in total

1.  Work-related road traffic injury: a multilevel systems protocol.

Authors:  Sharon Newnam; Dianne M Sheppard; Mark A Griffin; Roderick J McClure; Gillian Heller; Malcolm R Sim; Mark R Stevenson
Journal:  Inj Prev       Date:  2014-01-29       Impact factor: 2.399

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.